Memory decline in the aged
Treatment with lecithin and physostigmine
Abstract
Normal aged subjects were given lecithin and placebo for 5 weeks each in a double-blind crossover study. Supraspan tests of memory and learning failed to show any significant changes as a result of these treatments. Addition of a single IV infusion of physostigmine did not improve performance. These findings neither support nor weaken the “cholinergic hypothesis” of cognitive impairment in aging and dementia, but they imply that simple cholinergic hypofunction is unlikely.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Copyright
© 1982 by the American Academy of Neurology.
Publication History
Published online: September 1, 1982
Published in print: September 1982
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Late cognitive and radiographic changes related to radiotherapy, Neurology, 59, 1, (40-48), (2023)./doi/10.1212/WNL.59.1.40
- Choline Intake and Cognitive Function Among U.S. Older Adults, Journal of Nutrition in Gerontology and Geriatrics, 42, 1, (30-45), (2023).https://doi.org/10.1080/21551197.2023.2179565
- Targeting DNA Methylation in the Adult Brain through Diet, Nutrients, 13, 11, (3979), (2021).https://doi.org/10.3390/nu13113979
- Chronic traumatic encephalopathy and the nucleus basalis of Meynert, The Human Hypothalamus: Neuropsychiatric Disorders, (9-29), (2021).https://doi.org/10.1016/B978-0-12-819973-2.00002-2
- The Cholinergic Neurotransmitter System in Human Memory and Dementia: A Review, The Quarterly Journal of Experimental Psychology Section A, 38, 4, (535-573), (2018).https://doi.org/10.1080/14640748608401614
- A Comprehensive Review of Eggs, Choline, and Lutein on Cognition Across the Life-span, Journal of the American College of Nutrition, 37, 4, (269-285), (2018).https://doi.org/10.1080/07315724.2017.1423248
- Issues in the clinical diagnosis of Alzheimer's disease, American Journal of Alzheimer's Care and Related Disorders, 1, 1, (9-15), (2016).https://doi.org/10.1177/153331758600100104
- Pharmacotherapy of Memory Loss in the Geriatric Patient, Drug Intelligence & Clinical Pharmacy, 18, 10, (784-791), (2016).https://doi.org/10.1177/106002808401801002
- The ‘tomato effect’ in clinical nutrition, Postgraduate Medicine, 76, 8, (49-65), (2016).https://doi.org/10.1080/00325481.1984.11698814
- Neurotransmitter Deficits in Alzheimer's Disease: Criteria for Significance, Journal of the American Geriatrics Society, 31, 5, (310-316), (2015).https://doi.org/10.1111/j.1532-5415.1983.tb04877.x
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.